EXAS vs EXPI · rev $2.76B vs rev $4.57B
EXACT Sciences Corporation (EXAS) versus eXp World Holdings Inc (EXPI) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
eXp World Holdings Inc (EXPI) is a real estate services company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported EXPI revenue for 2024-12-31 was $4.57B. Net income was -$21.3M. Revenue was up 6.9% from 2023-12-31 to 2024-12-31. EXPI currently screens at market cap $1.45B.
EXAS currently screens at market cap $20.03B. EXPI currently screens at market cap $1.45B.
Not investment advice. Open the EXAS and EXPI stock pages for the full models.
Not investment advice.